Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.
IPO Year: 2010
Exchange: NASDAQ
Website: horizontechfinance.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/5/2026 | $5.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 5/13/2025 | $7.00 | Neutral | B. Riley Securities |
| 4/30/2025 | $6.50 | Neutral → Sell | Compass Point |
| 12/17/2024 | $8.25 | Sell → Neutral | Compass Point |
| 2/28/2024 | Buy → Neutral | Ladenburg Thalmann | |
| 1/8/2024 | $11.00 | Neutral → Sell | B. Riley Securities |
| 10/17/2023 | $10.00 | Neutral → Sell | Compass Point |
| 9/27/2023 | $11.00 → $10.50 | Sell → Neutral | Compass Point |
| 8/4/2023 | $11.00 | Neutral → Sell | Compass Point |
| 4/11/2023 | $12.50 | Buy | Ladenburg Thalmann |
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
DEFA14A - Horizon Technology Finance Corp (0001487428) (Filer)
424B3 - Horizon Technology Finance Corp (0001487428) (Filer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
424B3 - Horizon Technology Finance Corp (0001487428) (Filer)
10-K - Horizon Technology Finance Corp (0001487428) (Filer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
Fastest customizable press release news feed in the world
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), an affiliate of Monroe Capital, announced today the formation of a new joint venture with CR Financial Holdings, Inc. ("CRFH"), the holding company for Roth Capital Partners, LLC ("Roth"). The joint venture will provide growth capital financing solutions to small- and micro-cap public companies based primarily in the U.S. Horizon and CRFH will make initial capital commitments totaling $100 million. The joint venture intends to leverage its initial capital by entering into warehouse credit facilities from time to time. Governance and investment decisions will be made by a four-person board and a four-person investment commit
FARMINGTON, Conn. and CHICAGO, March 16, 2026 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (("HRZN", NASDAQ:HRZN) announced today that its shareholders, at a special meeting held on March 13, 2026, approved the issuance of HRZN's common stock (the "HRZN Share Issuance Proposal") in connection with the proposed merger of Monroe Capital Corporation (NASDAQ:MRCC) ("MRCC") with and into HRZN (the "Merger"). In addition, MRCC announced today that its shareholders, at a special meeting held on March 13, 2026, approved: (1) the proposed Merger and (2) the related proposed sale of substantially all of MRCC's assets to Monroe Capital Income Plus Corporation ("MCIP") at fair value for
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN"), an affiliate of Monroe Capital LLC, today announced its Board of Directors' intent to supplement HRZN's regular monthly distributions to HRZN stockholders following the closing of the pending merger (the "Merger") between HRZN and Monroe Capital Corporation ("MRCC"). As previously announced, following the Merger, HRZN will be the surviving public entity and will continue to be managed by Horizon Technology Finance Management LLC ("HTFM") and trade on the NASDAQ under the symbol "HRZN". To create near-term value for the post-Merger combined company stockholders, the HRZN Board intends to use HRZN's current undistributed taxable
SADDLE BROOK, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Bulldog Investors, LLP ("Bulldog"), one of the largest shareholders of Monroe Capital Corporation (NASDAQ:MRCC), holding 954,816 shares, announced today that it is urging Monroe's Board of Directors to reconsider the proposed merger of Monroe into Horizon Technology Finance Corporation (NASDAQ:HRZN). When the proposed merger of Monroe into Horizon on a net asset value ("NAV") for NAV basis was announced seven months ago, shareholders of Monroe were told that they would "realize [an] immediate 33% NAV premium to current trading price," which was $6.21 at that time and a discount to its NAV of $8.29. At that time, Horizon's shares were
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, announced today that its board of directors has declared monthly cash distributions of $0.06 per share, payable in each of April, May and June 2026. The following tables show these distributions, payable as set forth in the tables below, total $0.18 per share. Since its 2010 initial public offering, Horizon has paid a total of $360 million in distributions to its shareholders. Monthly Distributions Declared in First Quarter 2026 Ex-Dividend Date Record Date Payment Date Amount per Share March 16, 2026 March 16, 2026 April 15,
- Fourth Quarter 2025 Net Investment Income per Share of $0.18; NAV per Share of $6.98 - - Debt Portfolio Yield of 14.3% - - HRZN Ends Year with Committed Backlog of $154 Million - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 and Recent Highlights Net investment income ("NII") of $8.3 million, or $0.18 per basic share, compared to $10.4 million, or $0.27 per basic share for the prior-year period Total investment portfolio of $647.2 million as of December 31, 2025 Net asset value of $318.
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, announced today that it plans to release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, March 4, 2026, at 9:00 a.m. ET. The conference call will feature remarks by Mike Balkin, Chief Executive Officer, Paul Seitz, Senior Vice President and Chief Investment Officer, and Dan Trolio, Executive Vice President and Chief Financial Officer. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (interna
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon"), together with Monroe Capital LLC ("Monroe"), today announced the closing of an initial $40 million senior credit facility for Ossio Inc. ("OSSIO"), with an additional $10 million available to support future growth. Founded in 2014, OSSIO is an orthopedics company committed to transforming the surgical experience for patients, physicians, providers and payors. The company's vision is to provide the first credible replacement for metal implants in the multibillion-dollar global orthopedic fixation market with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIO conducts product development and manufacturing in Caesarea,
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, today announced it has provided a $50 million venture loan facility to Pelthos Therapeutics Inc. (NYSE:PTHS) ("Pelthos"), with an initial funding of $30 million, and up to $20 million to support future growth. Pelthos is a publicly traded biopharmaceutical company that is licensed to commercialize ZELSUVMI™ (berdazimer) topical gel, an FDA-approved treatment of molluscum contagiosum, a common skin infection characterized by small bumps or lesions. ZELSUVMI delivers nitric oxide directly to the affected skin or tissue via the Nitricil platform, which enables the gel to slowly a
DURHAM, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE:PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs ("Pelthos"), today announced it has secured financing from Horizon Technology Finance Corporation ("Horizon") (NASDAQ:HRZN), an affiliate of Monroe Capital, with an initial funding of $30 million, and up to $20 million to support future growth. "We believe this transaction with Horizon gives Pelthos the flexibility and resources to accelerate the commercialization of our cutaneous infectious disease product portfolio, strengthens our balance sheet, and most importantly, brings ZELSUVMI, the f
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Keefe Bruyette upgraded Horizon Technology Finance from Underperform to Mkt Perform and set a new price target of $5.00
B. Riley Securities resumed coverage of Horizon Technology Finance with a rating of Neutral and set a new price target of $7.00
Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $6.50
Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25
Ladenburg Thalmann downgraded Horizon Technology Finance from Buy to Neutral
B. Riley Securities downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $11.00
Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $10.00
Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $10.50 from $11.00 previously
Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $11.00
Ladenburg Thalmann initiated coverage of Horizon Technology Finance with a rating of Buy and set a new price target of $12.50
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
3 - Horizon Technology Finance Corp (0001487428) (Issuer)
3 - Horizon Technology Finance Corp (0001487428) (Issuer)
3 - Horizon Technology Finance Corp (0001487428) (Issuer)
Live Leadership Updates
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or "HRZN") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity backed and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it has appointed Paul Seitz as its new Chief Investment Officer. Concurrently, Daniel Devorsetz has stepped down as Chief Operating Officer and Chief Investment Officer, but will remain involved with the Company through September 2025. "We are thrilled to welcome Paul as our new Chi
Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr
FARMINGTON, Conn., June 9, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon," or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that it has appointed Daniel S. Devorsetz as Chief Operating Officer effective immediately. In addition, Devorsetz has concurrently been appointed as Chief Operating Officer of Horizon's external investment advisor, Horizon Technology Finance Management LLC (the "Advisor" or "HTFM"). He currently serves as Chief Investment Of
Live finance-specific insights
FARMINGTON, Conn. and CHICAGO, March 16, 2026 (GLOBE NEWSWIRE) -- Horizon Technology Finance Corporation (("HRZN", NASDAQ:HRZN) announced today that its shareholders, at a special meeting held on March 13, 2026, approved the issuance of HRZN's common stock (the "HRZN Share Issuance Proposal") in connection with the proposed merger of Monroe Capital Corporation (NASDAQ:MRCC) ("MRCC") with and into HRZN (the "Merger"). In addition, MRCC announced today that its shareholders, at a special meeting held on March 13, 2026, approved: (1) the proposed Merger and (2) the related proposed sale of substantially all of MRCC's assets to Monroe Capital Income Plus Corporation ("MCIP") at fair value for
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN"), an affiliate of Monroe Capital LLC, today announced its Board of Directors' intent to supplement HRZN's regular monthly distributions to HRZN stockholders following the closing of the pending merger (the "Merger") between HRZN and Monroe Capital Corporation ("MRCC"). As previously announced, following the Merger, HRZN will be the surviving public entity and will continue to be managed by Horizon Technology Finance Management LLC ("HTFM") and trade on the NASDAQ under the symbol "HRZN". To create near-term value for the post-Merger combined company stockholders, the HRZN Board intends to use HRZN's current undistributed taxable
SADDLE BROOK, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Bulldog Investors, LLP ("Bulldog"), one of the largest shareholders of Monroe Capital Corporation (NASDAQ:MRCC), holding 954,816 shares, announced today that it is urging Monroe's Board of Directors to reconsider the proposed merger of Monroe into Horizon Technology Finance Corporation (NASDAQ:HRZN). When the proposed merger of Monroe into Horizon on a net asset value ("NAV") for NAV basis was announced seven months ago, shareholders of Monroe were told that they would "realize [an] immediate 33% NAV premium to current trading price," which was $6.21 at that time and a discount to its NAV of $8.29. At that time, Horizon's shares were
- Fourth Quarter 2025 Net Investment Income per Share of $0.18; NAV per Share of $6.98 - - Debt Portfolio Yield of 14.3% - - HRZN Ends Year with Committed Backlog of $154 Million - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 and Recent Highlights Net investment income ("NII") of $8.3 million, or $0.18 per basic share, compared to $10.4 million, or $0.27 per basic share for the prior-year period Total investment portfolio of $647.2 million as of December 31, 2025 Net asset value of $318.
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, announced today that it plans to release financial results for the fourth quarter ended December 31, 2025 on Tuesday, March 3, 2026, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, March 4, 2026, at 9:00 a.m. ET. The conference call will feature remarks by Mike Balkin, Chief Executive Officer, Paul Seitz, Senior Vice President and Chief Investment Officer, and Dan Trolio, Executive Vice President and Chief Financial Officer. To participate in the call, please dial (877) 407-9716 (domestic) or (201) 493-6779 (interna
- Third Quarter 2025 Net Investment Income per Share of $0.32; NAV per Share of $7.12 - - Debt Portfolio Yield of 18.6% - - HRZN Ends Quarter with Committed Backlog of $119 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through March 2026 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the third quarter ended September 30, 2025 on Tuesday, October 28, 2025, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, October 29, 2025, at 9:00 a.m. ET. The conference call will
- Second Quarter 2025 Net Investment Income per Share of $0.28; NAV per Share of $6.75 - - Debt Portfolio Yield of 15.8% - - HRZN Ends Quarter with Committed Backlog of $149 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through December 2025 - - Announced Merger with Monroe Capital Corp (NASDAQ:MRCC) - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and serv
Monroe Capital Corporation Additionally Signs Definitive Asset Purchase Agreement to Sell its Investment Assets to Monroe Capital Income Plus Corporation Immediately Preceding Merger Transaction to Drive Scale and Shareholder Value Across Monroe Capital BDC Platforms Monroe Capital LLC ("Monroe Capital") today announced that Monroe Capital Corporation (("MRCC", NASDAQ:MRCC) and Horizon Technology Finance Corporation (("HRZN", NASDAQ:HRZN), both business development companies ("BDCs") managed by affiliates of Monroe Capital, have entered into an agreement (the "Merger Agreement") under which MRCC would merge with and into HRZN (the "Merger"), subject to the receipt of certain shareholder
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the second quarter ended June 30, 2025 on Thursday, August 7, 2025, after the close of market trading. The Company has scheduled a conference call to discuss the results on Thursday, August 7, 2025, at 5:00 p.m. ET. The conference call will feature